WGS•benzinga•
Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Lowers Price Target to $78
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 1, 2025 by benzinga